2018
DOI: 10.4103/0028-3886.246273
|View full text |Cite
|
Sign up to set email alerts
|

Immune-mediated neurological manifestations of dengue virus- a study of clinico-investigational variability, predictors of neuraxial involvement, and outcome with the role of immunomodulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 0 publications
0
10
0
Order By: Relevance
“…patients with DENV infection 12 . In children, a study with 71 confirmed cases showed that 28.17% of the patients had neurological involvement 13 .…”
Section: Bhushan Et Al (2018) Found 486% Of Immune-mediated Neurolomentioning
confidence: 99%
See 4 more Smart Citations
“…patients with DENV infection 12 . In children, a study with 71 confirmed cases showed that 28.17% of the patients had neurological involvement 13 .…”
Section: Bhushan Et Al (2018) Found 486% Of Immune-mediated Neurolomentioning
confidence: 99%
“…GBS and its variants represent 5% of neurological complications in pediatric patients who had DF 13 , the period between the onsets of the illnesses of approximately 10,9 days 26 . Acute motor and sensitive axonal neuropathy (AMSAN) was the most common GBS subtype in these patients, followed by acute motor axonal neuropathy (AMAN), acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and Miller Fisher syndrome (MFS) 12 .…”
Section: Guillain-barre Syndromementioning
confidence: 99%
See 3 more Smart Citations